A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06532279

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:29:03.787012+00:00

Published At

2026-04-23T00:00:00+00:00

Record Updated At

2026-04-23

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8", "Head and Neck Squamous Cell Carcinoma", "Hypopharyngeal Squamous Cell Carcinoma", "Laryngeal Squamous Cell Carcinoma", "Nasopharyngeal Squamous Cell Carcinoma", "Oral Cavity Squamous Cell Carcinoma", "Oropharyngeal Squamous Cell Carcinoma", "Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage 0 Hypopharyngeal Carcinoma AJCC v8", "Stage 0 Nasopharyngeal Carcinoma AJCC v8", "Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage I Hypopharyngeal Carcinoma AJCC v8", "Stage I Laryngeal Cancer AJCC v8", "Stage I Lip and Oral Cavity Cancer AJCC v8", "Stage I Nasopharyngeal Carcinoma AJCC v8", "Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage II Hypopharyngeal Carcinoma AJCC v8", "Stage II Laryngeal Cancer AJCC v8", "Stage II Lip and Oral Cavity Cancer AJCC v8", "Stage II Nasopharyngeal Carcinoma AJCC v8", "Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8", "Stage III Hypopharyngeal Carcinoma AJCC v8", "Stage III Laryngeal Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage III Nasopharyngeal Carcinoma AJCC v8", "Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVA Hypopharyngeal Carcinoma AJCC v8", "Stage IVA Laryngeal Cancer AJCC v8", "Stage IVA Lip and Oral Cavity Cancer AJCC v8", "Stage IVA Nasopharyngeal Carcinoma AJCC v8", "Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stage IVB Hypopharyngeal Carcinoma AJCC v8", "Stage IVB Laryngeal Cancer AJCC v8", "Stage IVB Lip and Oral Cavity Cancer AJCC v8", "Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8", "Stomatitis"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-23"

protocolSection.identificationModule.nctId

"NCT06532279"

protocolSection.identificationModule.officialTitle

"A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Head and Neck Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Hypopharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Laryngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Nasopharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Oral Cavity Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Oropharyngeal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage 0 Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage 0 Nasopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Nasopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Nasopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Nasopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Nasopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Hypopharyngeal Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Laryngeal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Lip and Oral Cavity Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (protocolSection.conditionsModule.conditions)
• Stomatitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.